XOMA Co. (NASDAQ:XOMAO) Short Interest Down 40.0% in October

XOMA Co. (NASDAQ:XOMAO) was the target of a large decline in short interest in October. As of October 15th, there was short interest totalling 2,700 shares, a decline of 40.0% from the September 30th total of 4,500 shares. Based on an average daily volume of 4,900 shares, the short-interest ratio is currently 0.6 days.

XOMA Price Performance

NASDAQ XOMAO opened at $25.62 on Friday. The business has a 50 day simple moving average of $25.41 and a 200 day simple moving average of $25.26. XOMA has a 52-week low of $20.43 and a 52-week high of $25.87.

XOMA Company Profile

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.